Hitoshi Katada

854 total citations
46 papers, 592 citations indexed

About

Hitoshi Katada is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hitoshi Katada has authored 46 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hitoshi Katada's work include DNA and Nucleic Acid Chemistry (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and RNA Interference and Gene Delivery (7 papers). Hitoshi Katada is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and RNA Interference and Gene Delivery (7 papers). Hitoshi Katada collaborates with scholars based in Japan, United States and Tunisia. Hitoshi Katada's co-authors include Makoto Komiyama, Tomoyuki Igawa, Kunihiro Hattori, Futa Mimoto, Shojiro Kadono, Taichi Kuramochi, Kenta Haraya, Kenichiro Ito, Masaru Muraoka and Youichiro Wada and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Hitoshi Katada

41 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Katada Japan 14 361 204 120 79 65 46 592
Mark K. Boehm United Kingdom 11 368 1.0× 240 1.2× 163 1.4× 76 1.0× 56 0.9× 14 595
Christian Tiede United Kingdom 19 560 1.6× 231 1.1× 65 0.5× 60 0.8× 74 1.1× 43 822
Rodney A. Jue United States 10 330 0.9× 123 0.6× 55 0.5× 41 0.5× 64 1.0× 14 601
Francis Man United Kingdom 14 220 0.6× 215 1.1× 127 1.1× 75 0.9× 172 2.6× 24 778
Hyori Kim South Korea 13 283 0.8× 112 0.5× 98 0.8× 104 1.3× 130 2.0× 48 731
Daniel M. Scott United States 14 195 0.5× 156 0.8× 61 0.5× 182 2.3× 37 0.6× 17 590
Jarkko Karvinen Finland 10 283 0.8× 90 0.4× 54 0.5× 113 1.4× 62 1.0× 13 497
Hiroaki Takahashi Japan 9 446 1.2× 171 0.8× 204 1.7× 40 0.5× 76 1.2× 26 634
Kimberly May United States 9 745 2.1× 599 2.9× 207 1.7× 27 0.3× 144 2.2× 13 1.0k
Maria C. Alcaro Italy 15 394 1.1× 150 0.7× 222 1.9× 18 0.2× 72 1.1× 23 746

Countries citing papers authored by Hitoshi Katada

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Katada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Katada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Katada more than expected).

Fields of papers citing papers by Hitoshi Katada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Katada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Katada. The network helps show where Hitoshi Katada may publish in the future.

Co-authorship network of co-authors of Hitoshi Katada

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Katada. A scholar is included among the top collaborators of Hitoshi Katada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Katada. Hitoshi Katada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katada, Hitoshi, et al.. (2023). Preclinical <i>in vitro</i> evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibody. The Journal of Toxicological Sciences. 48(7). 399–409.
2.
Mimoto, Futa, Taichi Kuramochi, Hitoshi Katada, Tomoyuki Igawa, & Kunihiro Hattori. (2016). Fc Engineering to Improve the Function of Therapeutic Antibodies. Current Pharmaceutical Biotechnology. 17(15). 1298–1314. 12 indexed citations
3.
Mimoto, Futa, Hitoshi Katada, Shojiro Kadono, et al.. (2013). Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131. Protein Engineering Design and Selection. 26(10). 589–598. 101 indexed citations
4.
Mimoto, Futa, et al.. (2013). Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs. Molecular Immunology. 58(1). 132–138. 22 indexed citations
5.
Mimoto, Futa, Tomoyuki Igawa, Taichi Kuramochi, et al.. (2013). Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant. mAbs. 5(2). 229–236. 59 indexed citations
6.
Katada, Hitoshi & Makoto Komiyama. (2011). Artificial Restriction DNA Cutters to Promote Homologous Recombination in Human Cells. Current Gene Therapy. 11(1). 38–45. 26 indexed citations
7.
Kuzuya, Akinori, et al.. (2011). Enzyme Treatment-Free and Ligation-Independent Cloning Using Caged Primers in Polymerase Chain Reactions. Molecules. 17(1). 328–340. 9 indexed citations
8.
Ito, Kenichiro, et al.. (2009). Site-selective scission of human genome by artificial restriction DNA cutter. Chemical Communications. 6542–6542. 25 indexed citations
9.
Katada, Hitoshi, et al.. (2009). Homologous recombination in human cells using artificial restriction DNA cutter. Chemical Communications. 6545–6545. 29 indexed citations
10.
Katada, Hitoshi, Hidetake Seino, Y. Mizobe, Jun Sumaoka, & Makoto Komiyama. (2007). Crystal structure of Ce(IV)/dipicolinate complex as catalyst for DNA hydrolysis. JBIC Journal of Biological Inorganic Chemistry. 13(2). 249–255. 24 indexed citations
11.
Hamada, Kaoru, Takeshi Tokuyama, Yukinori Okamoto, et al.. (1999). A Clinicopathological Study of Lung Cancer Patients with Occupational Exposure to Chrysotile Asbestos Fibers.. Internal Medicine. 38(10). 780–784. 4 indexed citations
12.
Katada, Hitoshi, et al.. (1991). A case of bronchiolo-alveolar carcinoma with lipoid pnemonia presenting as a cavitary lesion with neveau formation.. Haigan. 31(1). 119–124. 1 indexed citations
13.
14.
Fukuoka, Kohei, Satoru Morikawa, Hiroyuki Watanabe, et al.. (1989). [A case of multiple small pulmonary arteriovenous fistulas with chronic hepatitis and abdominal vessel abnormalities].. PubMed. 27(11). 1362–6. 1 indexed citations
15.
Katada, Hitoshi, et al.. (1985). A case of pulmonary adenocarcinoma presenting as a solitary thin-walled cavity.. Haigan. 25(7). 1043–1048.
16.
Mikasa, Keiichi, Hitoshi Katada, Shinsaku Ito, et al.. (1985). Transmyocardial metastasis of a lung cancer showing a recent myocardial infarction-like ECG: Report of a case with autopsy findings.. Haigan. 25(1). 93–98. 2 indexed citations
17.
Katada, Hitoshi, Riichiro Mikami, Kiyoshi Nishikawa, et al.. (1984). SERUM IgE LEVEL IN PULMONARY TUBERCULOSIS. 59(9). 483–490. 1 indexed citations
18.
Katada, Hitoshi, et al.. (1984). A case of bronchiolo-alveolar type papillary adenocarcinoma presenting with multiple cavities.. Haigan. 24(6). 743–748. 3 indexed citations
19.
Katada, Hitoshi, Satoaki Nakamura, Takeshi Horai, et al.. (1980). Combined therapy and cytological findings on inoperable early lung cancer originated from the major bronchus. Haigan. 20(1). 49–57. 2 indexed citations
20.
Katada, Hitoshi, et al.. (1978). [On the acute toxicity of labetalol (AH-5158), a combined alpha-and-beta-adrenoceptor-blocking agent (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(1). 15–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark K. Boehm Breakdown of academic impact, for papers by Christian Tiede Breakdown of academic impact, for papers by Rodney A. Jue Breakdown of academic impact, for papers by Francis Man Breakdown of academic impact, for papers by Hyori Kim Breakdown of academic impact, for papers by Daniel M. Scott Breakdown of academic impact, for papers by Jarkko Karvinen Breakdown of academic impact, for papers by Hiroaki Takahashi Breakdown of academic impact, for papers by Kimberly May Breakdown of academic impact, for papers by Maria C. Alcaro
Rankless by CCL
2026